Saturday, 26 November 2016

PRACTICAL 3 ASSESSMENT OF QUALITY OF TABLETS AND CAPSULES

TITLE
Assessment of Quality of Tablets and Capsules

AIM
1.  To examine the shape, colour, diameter, thickness and/or other physical characteristics.
2.      To measure the uniformity of diameter, thickness and hardness of tablets.
3.      To determine the tablet friability.
4.      To determine the uniformity of weight of tablets and capsules.
5.      To discover the content of ibuprofen (assay).

DATE OF EXPERIMENT
21st November 2016

INTRODUCTION
Tablets and capsules are the example of the oral dosage form used. Like all other dosage forms, they are subjected to those pharmacopoeial standards dealing to the “added substances” respecting their toxicity, interference with analytical methods and more. There are certain procedures that is applied specifically to tablets and capsules and they are designed to ensure that a tablet or a capsule exerts its full pharmacological actions. Furthermore, they also to determine the uniformity of the physical properties of the official tablet or capsule. These standards are found in the British Pharmacopoeia and United Pharmacopoeia and they include, uniformity of diameter, uniformity of weight (mass), content of active ingredient, uniformity of content, friability, disintegration and dissolution. There are a number of quality control procedures that is widely applied but are not defined by the pharmacopoeias such as the thickness, and hardness.

In this assessment, there are five experiments conducted:
      1.      Examining the characteristics of tablets and capsules.
      2.      Testing the uniformity of diameter, thickness and hardness.
      3.      Testing the tablet friability
      4.      Testing the uniformity of weight of tablets and capsules.
      5.      Content of ibuprofen (assay)

Experiment 1: Physical Appearance
Procedures:
      1)      One tablet and capsule were selected randomly from the provided samples. The shape, colour, diameter, thickness and other physical characteristics were examined and determined for the samples chosen.
Results:

Characteristics
Tablet
Capsule
Shape
Oval
Cylindrical with hemispherical ends
Colour
Pink
Red and Black
Diameter
1.8 cm
0.6 cm
Thickness
0.5 cm
-
Other physical characteristics
Brand – APP
Weight – 250 mg
Brand – AMPILLIN
Weight – 250 mg
Length – 1.7 cm


Experiment 2: Uniformity of diameter, thickness and hardness
Procedures:
      1.      10 tablets are selected and carried out tests for uniformity of diameter, thickness and hardness using the Tablet Testing Instrument (PHARMATEST PTB 311)



      2.      The deviation of individual unit from the mean diameter should not exceed ±5% for tablets with diameter of less than 12.5 and ±3% for diameter of 12.5mm or more.

Results:
Tablet
Thickness (mm)
Diameter (mm)
Hardness (N)
Deviation of diameter (%)
1
5.45
13.16
113.80
0.228
2
5.48
13.11
150.01
-0.152
3
5.50
13.11
150.01
-0.152
4
5.47
13.12
137.08
-0.076
5
5.42
13.12
122.30
-0.076
6
5.45
13.11
143.55
-0.152
7
5.33
13.17
138.19
0.305
8
5.47
13.14
203.78
0.076
9
5.44
13.13
175.32
0.000
10
5.48
13.12
118.98
-0.076
Mean:
5.45
13.13
145.30

Formula for deviation = x100%


The tablets are manufactured by compression of the powder with force. So the thickness of tablet depends on the amount of force applied during the compression to produce the tablet. When larger force is applied, the tablet will be more compact and thinner. A compact tablet will takes a longer time to dissolve and disintegrate, so the absorption of drug by our body will be slower. If the tablet is thick then it might break easily because the particles are not compressed to compact. This cause the tablet couldn’t survive the whole manufacturing process or might break before use by patients. Therefore it is very important to achieve the optimum thickness for the tablet. In this experiment, we used Tablet Testing Instrument (PHARMATEST PTB 311) to measure the thickness, diameter and the hardness of the tablet. The mean thickness of the tablet from the result of the experiment is 5.45mm. The mean diameter for the tablets in the experiment is 13.13mm, so the tolerance for the tablets deviation of individuals unit from the mean diameter must not exceed ±3%. From the result table, it shows that the deviation of the individual unit does not exceed ±3%, the deviation at most only 0.305%. Thus, we can confirm that the tablets have uniform diameters.

Experiment 3 : Tablet friability
Procedures :
      1.      10 tablets were selected and weighed.


      2.      All tablets were put into the drum of the tablet abration and friability tester. The rate of rotation was set to 25 rpm, time to 10 minutes and the operation was started.



      3.      At the end of operation, all the tablets were removed and the dust or powder on the tablets was cleaned by using brush. The tablets were reweighed. The percentage loss of weight was determined.

Results :
Original weight of 10 tablets
5.7811g
Weight of 10 tablets after the test
5.7583g
Weight of loss
0.0228g
Percentage loss of weight

Discussion :
            The objective of testing the friability of tablet is to ensure the stability of tablets during collision in the bottle. To do this, the tablet abration and friability tester is used as a standard to test the tablet friability. During the test, the dust and powder on the tablets were cleaned with brush before reweighing for the second time to determine the loss of weight. This is a precaution to ensure the accuracy of the results.
According to the results, only 0.39% of the weight was lost after the friability test. Since the percentage of lose weight does not exceed 1%, hence, we can say that the friability of tablets is satisfactory.

Experiment 4: Uniformity of weight of tablets and capsules
Procedures :
Tablets
1.     20 tablets from previously selected at random were weighed and the average weight was determined.
2.     Then, the tablets were individually being weighed and the percentage deviation of its weight from the average weight was determine for each tablet.


3.     The deviation of individual weight from the average weight should not exceed the limits given below.

Capsules
1.     20 capsules were selected at random.
2.     One capsule was weighed. Capsule was opened and the content was removed completely as possible. The emptied shell was weighed. The net weight of its contents was determined, that was by subtracting the weight of the shells from the weight of the intact capsule.



3.     The procedure was repeated with other 19 capsules.
4.     The average net weight from the sum of the individual net weights was determined.
5.     The percentage deviation from the average net weight for each capsules was determined. The deviation of individual net weight should not exceed the limits given below.

Results :
Tablet
No.
Weight of tablet (g)
Deviation
Weight (mg)
Percentage (%)
1.       
0.6427
+0.7
0.11
2.       
0.6293
-12.7
1.98
3.       
0.6345
-7.5
1.17
4.       
0.6092
-32.8
5.11
5.       
0.6362
-5.8
0.90
6.       
0.6285
-13.5
2.10
7.       
0.6636
+21.6
3.36
8.       
0.6331
-8.9
1.39
9.       
0.6458
+3.8
0.59
10.   
0.6449
+2.9
0.45
      11.   
0.6686
+26.6
4.14
12.   
0.6426
+0.6
0.09
13.   
0.6416
-0.4
0.06
14.   
0.6324
-9.6
1.50
15.   
0.6330
-0.9
0.14
16.   
0.6305
-11.5
1.79
17.   
0.6471
+5.1
0.79
18.   
0.6690
+2.7
0.42
19.   
0.6405
-1.5
0.23
20.   
0.6663
+24.3
3.79

Average weight of tablet = total weight of 20 tablet / 20
Average weight = 12.8394g / 20
= 0.6420g

Deviation in percentage is calculated using the formula below:
Deviation (%) = (weight of individual tablet) – (average weight of tablet) X  100%
                                    Average weight of tablet
Number of tablets have percentage of deviation ±5.0 = 19
Number of tablets have percentage of deviation ±10.0 =
1

Capsule
No.
Weight of capsule(g)
Weight of capsule shell (g)
Net weight of capsule (g)
Deviation
Weight (mg)
Percentage (%)
1.       
0.4688
0.0748
0.3940
+4.6
1.18
2.       
0.4680
0.0733
0.3947
+5.3
1.36
3.       
0.4604
0.0816
0.3788
-10.6
2.72
4.       
0.4708
0.0759
0.3949
+5.5
1.41
5.       
0.4718
0.0764
0.3954
+0.6
0.15
6.       
0.4756
0.0804
0.3952
+5.8
1.49
7.       
0.4748
0.0799
0.3949
+5.5
1.41
8.       
0.4557
0.0743
0.3814
-0.8
0.21
9.       
0.4803
0.0795
0.4008
+11.4
2.93
10.   
0.4674
0.0797
0.3877
-1.7
0.44
     11.   
0.4726
0.0776
0.3950
+5.6
1.44
12.   
0.4742
0.0810
0.3932
+3.8
0.98
13.   
0.4669
0.0767
0.3902
+0.8
0.21
14.   
0.4569
0.0819
0.3750
-14.4
3.70
15.   
0.4644
0.0786
0.3858
-3.6
0.92
16.   
0.4596
0.0768
0.3828
-6.6
1.69
17.   
0.4614
0.0823
0.3791
-10.3
2.65
18.   
0.4720
0.0775
0.3945
+5.1
1.31
19.   
0.4613
0.0790
0.3823
-7.1
1.82
20.   
0.4658
0.0735
0.3923
+2.9
0.74

Net weight of 20 capsules: 7.7880g
Average net weight of capsule = net weight of 20 capsules/ 20
Average net weight = 7.7880g / 20
= 0.3884g

Deviation in percentage is calculated using the formula below:
Deviation (%) = (net weight of individual capsule) – (average net weight of tablet) X 100%
                                    Average net weight of tablet
Number of capsules have percentage of deviation ±5.0 = 20
Number of
capsules have percentage of deviation ±10.0 = 0

Discussion:
Based on the experiment, the uniformity of weight of tablets and capsules were determined respectively in order to make sure that the dosage units are consistent. The average weight of the tablets obtained was 0.6420 g. Since the average weight obtained is more than 250 mg, minimum 18 tablets did not deviate from 0.6420 g by 5 %. Maximum 2 tablets did not deviate from 0.6420 g by 10 %. The uniformity of the tablets weighed had minimal deviation between the range and fall within the range limit of weight. The average weight obtained for the capsules was 0.3894 g. Since the average weight obtained is more than 300 mg, minimum 18 capsules did not deviate from 0.3894 g by 7.5 % and maximum 2 capsules did not deviate from the average weight by 15 %. The uniformity of the capsules weighed had minimal deviation and fall within the range limit of weight. Therefore, all the tablets and capsules passed the test conducted and both are considered as a successful batch respectively.

Besides, the results of the test of uniformity of weight for capsules may not be that accurate as there is might be some powder left in the capsules when they were emptied from the shells. As a precaution, the shells of capsules should always be completely emptied before weighing in order to increase the accuracy of result.

Questions
1.      What are the objectives of the tests for uniformity of diameter and uniformity of content?
To identify the uniformity of diameter, thickness and hardness for 10 samples of tablet. To test the ability for tablet to withstand sufficient mechanical strength and fracture/ erosion during manufacturing and handling.

2.  State the types of tablets and capsules that must be tested for uniformity of diameter and uniformity of content.
All the uncoated and coated tablets except the enteric tablets, film-coated tablets and sugar-coated tablets. Whereas, the uniformity of content tests normally involves single dose preparations. Tablets and capsules included are coated tablets, others than film-coated tablets containing 50mg or more of an active ingredient that comprises 50% or more of one tablet. Tablets or capsules have active ingredients less than 5% are needed. Liquid-filled soft capsules, solids packaged in single-unit containers with or without added substances and solutions for inhalation packaged in glass or plastic ampules are not applicable for testing uniformity of content.

3.      Why is it important that tablets and capsules have uniform weight and content?
To ensure accurate and consistent dosage form to be administered by patients. The safety and efficacy of drug products can be guaranteed when their quality is reliable and reproducible from batch to batch.

4.      Give reasons for the non-compliance to test for uniformity of weight.
The reasons for non-compliance to test for uniformity of weight are uneven feeding of granules into the die and due to irregular movement of the lower punch that cause variation in capacity die space. This result in unsatisfactory mix of ingredients at blending stage, and segregation of  compound in formulation is also can happen.

5.      Explain why is it beneficial for any tablets or capsules to have distinctive or identifying features.
Differences in features may affect patient compliance and acceptability of medication regimens. It could prevent medication errors when patients could mistaken having the same tablet twice if the features of medications given are similar.

Experiment 5 : Content of ibuprofen (assay)
Procedures :
1.      20 Ibuprofen Tablets previously selected at random were weighed and powdered.
2.   A quantity of powder containing 0.5g ibuprofen were extracted with 20ml chloroform for 15 minutes and was filtered through sintered glass crucible (BS Porosity No. 1).



3.  The residue were washed with 3 . 10 ml chloroform and the combined filtrate were gently evaporated just to dryness in a current of air. The residue were dissolved in 100ml with ethanol (96%) previously neutralized to phenolphthalein solution.
4.    The solution was titrated with 0.1 M sodium hydroxide to end point with phenolphthalein solution as the indicator. The content of ibuprofen was calculated if each ml of 0.1 M sodium hydroxide is equivalent to 0.002063 g of C13H18O2.




Results :
Calculate the powder of ibuprofen that contain 0.5g active ingredients of ibuprofen:
Weight of powder of ibuprofen = 10.97g
1 ibuprofen tablet contains 400mg active ingredients of ibuprofen
20 ibuprofen tablets contain 20 x 400mg = 8000mg (8g) of active ingredients of ibuprofen.
8g ibuprofen contain in 10.97g of tablet powder
0.5g ibuprofen contain in= 0.69g of tablet powder.

Thus, 0.69g of tablet powder was weighed and dissolved in 20ml of chloroform.

Calculate the weight of content of ibuprofen after titration:
C13H18O + NaOH = C12H17COONa + H2O
Volume of sodium hydroxide used = 14ml
Given that 1mL of 0.1M sodium hydroxide is equivalent to 0.02063g C13H18O2
So, the weight of Ibuprofen in the tablet is 14 x 0.02063g = 0.289g.

Percentage of standard deviation =x 100%
                                                            
                                                         =   x 100%
                                                         
                                                         = 57.8%

Discussion :
            From the calculation, we obtained a standard deviation of 57.8%. Based on the value given by British Pharmacopoeia (B.P.), the standard deviation accepted is between 90%-110% which proved that some errors occurred during the experiment because the percentage of standard deviation obtained from experiment is lower than the accepted value.
Firstly, some of the ibuprofen powder might left behind during weighing and filtration process. The powder might stick at the weighing boat when transferred to the conical flask and filter paper where the residue is not being filtered completely before we proceed to the next step. Then, the content of ibuprofen in powder given might be inaccurate or the ibuprofen tablets used were expired, these might cause the reduced in amount of ibuprofen. Another error might occur when drying the filtrate. The solution may not dry completely, causing to inaccurate results of mass of ibuprofen. In addition, error would occur during the titration with sodium hydroxide. This is because we titrated too fast and missed the first volume of sodium hydroxide to change the colourless solution changed to pink colour. To avoid this, we should titrate slowly with drop by drop because we were not sure about the volume needed.

CONCLUSION
To design drugs with similar size and shape so that the patients do not confuse, the uniformity of the diameter is important.  The thickness of the tablets is important in order to package the tablets either in blister or plastic container. The hardness of the tablets is important in order to ensure the drugs or tablets have effective hardness that will makes them dissolve in dissolution, but cannot easily break due to any pressure or forces applied to them.

REFERENCES

2.      http://www.pharmacopeia.cn/v29240/usp29nf24s0_m39890.html